"Antiseizure properties of cannabidiol (CBD) are attenuated in the absence of transient receptor potential vanilloid 1 (TRPV1) receptors (S53.004)." Neurology
90.15 Supplement
(2018):
S53.004.
Web. 25 May. 2022.
Advertisement
The most widely read and highly cited peer-reviewed neurology journal
